Loading…
20,252 grants found
Showing 1,981 – 2,000 of 20,252 grants
Project Summary/Abstract Breast cancer (BC) is the 2nd leading cause of cancer-related death in American women and metastasis is the major reason of BC-related mortality. Harnessin...
PROJECT SUMMARY/ABSTRACT Treating KRAS mutant lung adenocarcinoma (LUAD) remains a major challenge for clinical oncology. Approximately 20% of KRAS mutant LUAD tumors carry loss-of...
Project summary Diffuse large B cell lymphoma (DLBCL), a non-Hodgkin’s lymphoma, is the most common hematologic malignancy in the United States, and occurs in both adults and child...
PROJECT SUMMARY: The objective of this multi-principal investigator application is to leverage the complimentary expertise of the investigators to develop and credential multiple n...
PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDA) carries a dismal prognosis. Understanding the mechanisms that lead to the development of pancreatic cancer and to id...
PROJECT SUMMARY Among the most powerful and successful new therapies to enter the cancer clinic is CAR-T cell therapy. CAR- T cell therapy has been remarkably effective for patient...
PROJECT SUMMARY The overall survival rate for children with high-risk liver cancer, including metastatic or relapse/refractory hepatoblastoma (HB), hepatocellular carcinoma (HCC),...
ABSTRACT In addition to its pivotal roles in regulating cell cycle arrest, apoptosis, DNA repair, and metabolism, the p53 tumor suppressor has been demonstrated to modulate innate...
Cerebral cavernous malformations (CCMs) are vascular lesions in the central nervous system, affecting ~0.5% of the population. CCM patients experience debilitating neurological pro...
PROJECT SUMMARY/ABSTRACT In response to PAR-22-072: Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs, this project “Smoking and...
PROJECT SUMMARY The composition of microorganisms that inhabit the gut, known as the gut microbiome, has been strongly associated with the pathogenesis of several diseases includin...
PROJECT SUMMARY In the United States, colorectal cancer (CRC) mortality is markedly higher in African-American (AA) patients than any other racial or ethnic group. Treatment option...
ABSTRACT Of the 6,500 known rare diseases, only about 5% have U.S. Food and Drug Administration-approved treatments. In cancer, rare tumors account for approximately 20% of cancer...
ABSTRACT The overarching goal of the Sidney Kimmel Cancer Center (SKCC) is to leverage research expertise to reduce the overall incidence, burden, and mortality from cancer in Grea...
ABSTRACT Of the 6,500 known rare diseases, only about 5% have U.S. Food and Drug Administration-approved treatments. In cancer, rare tumors account for approximately 20% of cancer...
Abstract Breast cancer is the most diagnosed cancer and the second leading cause of cancer death in women in the USA. Immune checkpoint therapy (ICI) is revolutionizing the therapy...
Project Summary Prostate cancer is the most common malignancy and the second leading cause of cancer-related mortality in men in the United States. The American Urological Associat...
Project Summary Prostate cancer is the most common malignancy and the second leading cause of cancer-related mortality in men in the United States. The American Urological Associat...
PROJECT SUMMARY Few therapies have yet to achieve durable remission of advanced stage triple negative breast cancer (TNBC). One promising approach to improve clinical outcomes is t...
PROJECT SUMMARY/ABSTRACT The central KRAS-ERK signaling axis is activated in most human pancreatic adenocarcinomas (PDAC). Attempts to target ERK1 and ERK2 signaling with non-selec...